Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$249,757
-$47,104 QoQ
Shares Held
10,372
-1.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#2,268
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Counsel, Inc holds $4,343,317 across 8 Drug Manufacturers - General names. PFE ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
984 | $1,180,239 | |
| 2 | JNJ |
Johnson & Johnson
|
3,798 | $964,578 | |
| 3 | AMGN |
Amgen Inc
|
1,994 | $722,067 | |
| 4 | ABBV |
AbbVie Inc.
|
1,610 | $405,140 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,713 | $329,183 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,050 | $258,997 | |
| 7 | PFE |
Pfizer Inc
This page
|
10,372 | $249,757 | |
| 8 | MRK |
Merck & Co., Inc.
|
1,816 | $233,356 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $249,757 | 10,372 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $296,861 | 10,572 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $220,912 | 8,872 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $292,306 | 11,472 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $318,077 | 13,122 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $365,478 | 14,423 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $627,514 | 23,653 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $878,300 | 30,349 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $889,260 | 31,782 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $1,258,046 | 45,335 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,713,494 | 59,517 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $2,105,631 | 63,480 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $2,328,446 | 63,480 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,581,660 | 63,276 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $3,313,998 | 64,676 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $1,925,790 | 44,008 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $3,422,420 | 65,276 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $3,398,027 | 65,637 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,958,534 | 67,037 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $3,203,900 | 74,492 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $2,904,066 | 74,159 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $997,737 | 27,539 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $406,271 | 11,037 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,021,690 | 27,839 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $360,910 | 11,037 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $876,023 | 26,839 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||